Ocoee, Florida Clinical Trials

A listing of Ocoee, Florida clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
I am looking for
added new label for I am looking for
Advanced Filters
Found 52 clinical trials
A Study of Bermekimab (JNJ-77474462) in the Treatment of Participants With Moderate to Severe Atopic Dermatitis

The purpose of this study is to evaluate the efficacy and safety of bermekimab in participants with moderate to severe atopic dermatitis (AD).

topical agents
Accel Clinical Research
 (9.4 away) Contact site
  • 16 Jun, 2021
  • +47 other locations
Study to Evaluate Adverse Events and Change in Disease Activity in Participants Between 18 to 75 Years of Age Treated With Subcutaneous (SC) Injections of ABBV-154 for Moderately to Severely Active Rheumatoid Arthritis (RA)

Rheumatoid Arthritis (RA) is an inflammatory disease of the joints causing pain, stiffness, swelling and loss of joint function. This study evaluates how safe and effective ABBV-154 is in participants treated for moderately to severely active RA. Adverse events and change in the disease activity will be assessed. ABBV-154 is …

Omega Research Consultants /ID# 228293
 (7.1 away) Contact site
  • 17 Jun, 2021
  • +255 other locations
A Study Assessing the Efficacy and Safety of CBP-307 in Subjects With Moderate to Severe Ulcerative Colitis (UC)

This study will evaluate the efficacy and safety of CBP-307 in subjects with moderate to severe ulcerative colitis (UC).

Connect Investigative Site 2304
 (7.1 away) Contact site
  • 22 May, 2021
  • +76 other locations
Factor XI LICA to Reduce Events Such as Heart Attack and Stroke in Patients Whose Kidneys Are no Longer Able to Work as They Should and Require Treatment to Filter Wastes From the Blood: Focus is on the Safety of BAY2976217 and the Way the Body Absorbs Distributes and Removes the Study Drug

Patients whose kidneys are no longer able to work as they should and require treatment to filter wastes from the blood (hemodialysis) are at high risk for blood clots that form in blood vessels (thrombosis) blocking blood flow that causes heart attacks, strokes, and other life-threatening conditions. BAY2976217 is under …

DaVita Orlando North Dialysis
 (8.3 away) Contact site
  • 17 Jun, 2021
  • +102 other locations
Safety Study of Unlicensed Investigational Cord Blood Units Manufactured by the NCBP for Unrelated Transplantation

This study will evaluate the safety of infusion of the investigational cord blood units by carefully documenting all infusion-related problems.

Florida Hospital, Florida Center for Cellular Therapy
 (8.3 away) Contact site
  • 01 Mar, 2021
  • +68 other locations
Safety Tolerability Pharmacokinetics and Efficacy of EYP001a in Patients With Nonalcoholic Steatohepatitis (NASH)

The purpose of this study is to assess the effects of EYP001a with respect to safety, tolerability, pharmacokinetics and on markers of liver inflammation in patients with NASH

ENYO PHARMA Investigative site 0402
 (0.4 away) Contact site
  • 24 Jan, 2021
  • +34 other locations
Ricolinostat in Patients With Painful Diabetic Peripheral Neuropathy

This is a randomized, double-blind, 2-arm, parallel group study of up to 274 evaluable patients designed to evaluate the safety and efficacy of the histone deacetylase 6 (HDAC6) inhibitor ricolinostat for painful DPN.

ClinCloud LLC
 (10.6 away) Contact site
  • 02 May, 2021
  • +34 other locations
Phase 1/2a Clinical Trial of PR001A in Patients With Parkinson's Disease With at Least One GBA1 Mutation (PROPEL)

The study PRV-PD101 is evaluating a potentially disease-modifying, single-dose gene therapy for patients with Parkinson’s disease with GBA1 mutations (PD-GBA). PD-GBA is driven by mutations in the gene GBA1. This gene contains the instructions for making the lysosomal enzyme beta-glucocerebrosidase, or GCase, which is needed for the disposal and recycling of glycolipids — a type …

 (9.8 away) Contact site
  • 18 Sep, 2020
  • +3 other locations
A Study of TAK-954 to Treat Gastrointestinal Dysfunction in Adults After Surgery

The main aim of this study is to check for side effects from TAK-954 and whether it speeds up the recovery of gastrointestinal function after small-bowel or large-bowel resection surgery. Participants will be treated with TAK-954 before surgery and up to 10 days after surgery.

Center for Colon & Rectal Surgery - Altamonte Springs
 (8.3 away) Contact site
  • 16 May, 2021
  • +38 other locations
TTAC-0001 Phase II Trial With Recurrent Glioblastoma Progressed on Bevacizumab

This is a phase II, open-Label clinical trial to evaluate the safety and efficacy of TTAC-0001 in patients with recurrent glioblastoma who was progressed on bevacizumab including therapy.

neutrophil count
measurable disease
glioblastoma multiforme
Florida Hospital Cancer Institute & Florida Hospital Orlando
 (8.3 away) Contact site
  • 30 May, 2021
  • +2 other locations